VeClose trial reports “excellent” clinical and quality of life outcomes at two years


The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up with Raghu Kolluri (OhioHealth Vascular Institute, Columbus, USA) who explained his experience with the system thus far and why he is excited about the trial’s “excellent” 24-month outcomes.


(Visited 134 times, 1 visits today)